BUSINESS● LOWSep 29 · Sep 29, 2026, 4:35 PM
Invivyd drops after delaying late-stage trial data for COVID therapy
Seeking Alpha Tech · global
Invivyd's stock dropped after the company delayed the release of late-stage trial data for its COVID therapy. This indicates a potential setback for the company and its product development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowAir travel: between Dakar and Abidjan, which gateway for the Sahel?Jeune AfriqueBUSINESS35m agoPowerCell Q3 EPS loss widens as sales fall 61%Seeking Alpha Tech